Search by Drug Name or NDC

    NDC 00002-7637-11 ZYPREXA Details

    ZYPREXA

    ZYPREXA is a INTRAMUSCULAR KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is .

    Product Information

    NDC 00002-7637
    Product ID 0002-7637_41196744-bae3-4fee-86d2-2df9f7dc6a04
    Associated GPIs 59157060101970
    GCN Sequence Number 065793
    GCN Sequence Number Description olanzapine pamoate VIAL 405 MG INTRAMUSC
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 27848
    HICL Sequence Number 036716
    HICL Sequence Number Description OLANZAPINE PAMOATE
    Brand/Generic Brand
    Proprietary Name ZYPREXA
    Proprietary Name Suffix Relprevv
    Non-Proprietary Name Olanzapine pamoate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route INTRAMUSCULAR
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022173
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-7637-11 (00002763711)

    NDC Package Code 0002-7637-11
    Billing NDC 00002763711
    Package 1 KIT in 1 CARTON (0002-7637-11) * 2.7 mL in 1 VIAL (0002-7660-01) * 3 mL in 1 VIAL (0002-7622-01)
    Marketing Start Date 2010-03-01
    NDC Exclude Flag N
    Pricing Information N/A